echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Front Immunol: Male COVID19 patients had a higher mortality rate.

    Front Immunol: Male COVID19 patients had a higher mortality rate.

    • Last Update: 2020-10-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    September 24, 2020 /--- -- Men die more from COVID-19 than women, according to a new review by Israel's BIDMC Medical Center.
    a review published in Frontiers in Immunology, BIDMC researchers-clinicians looked at gender-based physiological differences that may affect the risk and susceptivity of COVID-19, the course and clinical outcomes of the disease, and the response to vaccines.
    "The COVID-19 outbreak is now showing significant gender differences, with a significant increase in male mortality compared to women," said co-author Dr. Vaishali R. Moulton, an assistant professor of medicine in the Department of Medicine.
    " In addition to differences in behavior and lifestyle factors between men and women, sex chromosome chain genes, sex hormones, and microbiomes control all aspects of the immune response to infection and may be important biological causes of our gender-based differences.
    " (Photo: www.pixabay.com) Moulton et al. argue that demographic differences between men and women put each group at different risk.
    , for example, men are more likely to smoke, which is a known risk factor for severe COVID-19, and are more likely to suffer from cardiovascular disease and high blood pressure, which is an important potential combination of COVID-19.
    women are more likely to work in health care, increasing their potential exposure to the virus.
    , however, many animal and human studies have shown that women have a stronger immune response to infection than men, a trait that may be associated with increased sensitivity to inflammatory and autoimmune diseases.
    Looking back at literature on gender-based differences in immune system cells, X chromosome chain genetics, sex hormones, ACE-2 ligands, and microbiomes, the scientists concluded that gender is a vital but under-studied and often overlooked variable.
    "Vaccine-related research and clinical trials, including ongoing research and clinical trials on COVID-19, must use gender as a key variable in measuring and reporting results," said Moulton, an assistant professor of medicine at Harvard Medical School in Washington, D.C.
    understanding these factors will help us better understand COVID-19 and guide the design of effective therapies and vaccine strategies toward gender-based personalized medicine.
    Bioon.com Source: COVID-19 mortality rates higher among men than women Source: Nirupa Gadi et al, What's Sex Got to Do With COVID-19? Gender-Based Differences in The Host Immune Response to Coronaviruses, Frontiers in Immunology (2020). DOI: 10.3389/fimmu.2020.02147.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.